Boston Scientific Corp. vs. Sensus Healthcare, Inc
Boston Scientific Corp. (BSX) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BSX | SRTS | |
|---|---|---|
| Market Cap | $65.19 billion | $52.02 million |
| Revenue (TTM) | $21.00 billion | $17.51 million |
| Net Income (TTM) | $3.67 billion | $-15,485,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | SRTS | |
|---|---|---|
| P/E Ratio | 18.20 | — |
| Price / Book | 2.59 | 1.41 |
| Price / Sales | 3.10 | 2.97 |
SRTS leads on 2 of 2 valuation factors.
Profitability
| BSX | SRTS | |
|---|---|---|
| Net Margin | 17.47% | -88.45% |
| Return on Equity | 14.58% | -42.01% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | SRTS | |
|---|---|---|
| Short Interest | 0.72% | 0.30% |
SRTS leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, SRTS overview, SRTS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.